vimarsana.com

Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, in a deal designed to expand the buyer’s immuno-inflammatory disease pipeline, led by Arena’s Phase II/II lead candidate etrasimod.

Related Keywords

Boston ,Massachusetts ,United States ,San Diego ,California ,Switzerland ,Bristol Myers Squibb Zeposia ,Josephp Schwartz ,Amitd Munshi ,Mike Gladstone ,Bristol Myers Squibb ,Schwartz ,Pfizer ,Arena Pharmaceuticals ,Pfizer Inflammation ,Aristea Therapeutics ,Park City ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.